Compare Amphastar Pharmaceuticals Inc (AMPH) vs Walmart Stores Inc (WMT) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Walmart (WMT) trades at $111.85, down 0.2% with a bearish technical signal despite strong fundamentals. The company reported consistent earnings beats in recent quarters with Q1 2026 EPS of $0.66 beating expectations. Revenue grew to $681B in 2025 with improving profit margins. Analyst consensus remains strongly bullish with a $142 price target, though technical indicators show near-term pressure with support at $109.

Walmart presents a compelling long-term investment with strong revenue growth and operational efficiency improvements. Key opportunities include expanding e-commerce capabilities and drone delivery services. Risks include competitive pressure from Amazon, margin compression from inflation, and legal challenges. The stock's current pullback may offer entry opportunity given Wall Street's positive outlook.